To explore the diagnosis efficacy of TRIM59, we performed ROC and SROC analyses to identify that high expression of TRIM59 showed a high diagnosis efficacy in each tumor type (AUC > 0.5), and with an AUC of summary ROC of 0.94 (0.91–0.96). This evidence concerns the gene TRIM59 and neoplasm.